Altis Biologics Porcine Osteogenic Bone Matrix (OBM) was funded by TIA to develop novel Porcine Osteogenic Bone Matrix (OBM) trauma products for skeletal regeneration in humans. The Altis OBM is an implant material intended as an alternative to traditional bone graft products. Traditional bone graft products usually involve the harvest of bone from the patient’s own hip or employ allograft donor bone supplied by bone tissue banks. Altis OBM is injected into the skeletal site requiring regeneration of new bone, without the need to perform a second bone graft operation.

Altis Biologics has successfully concluded a distribution agreement with a Brazilian distributor, Fort Med for the OBM and has been granted a license to market, sell and service the OBM in Brazil